Rodney Aulick - Aug 3, 2021 Form 4 Insider Report for Evoqua Water Technologies Corp. (AQUA)

Role
Executive Vice President
Signature
/s/ John DiMascio, Attorney-in-Fact for Rodney Aulick
Stock symbol
AQUA
Transactions as of
Aug 3, 2021
Transactions value $
-$288,839
Form type
4
Date filed
8/5/2021, 04:56 PM
Previous filing
Jul 7, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQUA Common Stock Options Exercise $165K +13K +11.42% $12.67 127K Aug 3, 2021 Direct F1, F2
transaction AQUA Common Stock Sale -$296K -8.51K -6.72% $34.71 118K Aug 3, 2021 Direct F1, F2, F3
transaction AQUA Common Stock Sale -$158K -4.47K -3.79% $35.28 114K Aug 3, 2021 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQUA Stock Option (Right to Buy) Options Exercise $0 -13K -33.33% $0.00 26K Aug 3, 2021 Common Stock 13K $12.67 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021.
F2 The amount of these securities includes 38,536 unvested restricted stock units in respect of the issuer's common stock.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.0100 to $35.0050, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 3 and 4 to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.0150 to $35.5550, inclusive.
F5 This option is scheduled to vest in equal installments on each of January 1, 2020, January 1, 2021, January 1, 2022 and January 1, 2023, subject to the reporting person's continued employment with the issuer through the applicable vesting date.